Home/Human Life CORD/Masamitsu Harata

MH

Masamitsu Harata

Founder, President, CEO, Chairman of the board

Human Life CORD

Therapeutic Areas

Immunology Respiratory Hematology Autoimmune

Human Life CORD Pipeline

Drug	Indication	Phase
HLC-001	Non-infectious pulmonary complications after hematopoietic stem cell transplantation (NIPCs)	Phase 3
Undisclosed	Autoimmune diseases	Non-clinical

Leadership Team at Human Life CORD

Nobutoshi Matsushita

Director of Overseas Business Planning, Senior Advisor (Global Strategy)

Tokiko Nagamura

Senior Advisor (Medical)

View full Human Life CORD profile